Literature DB >> 9150359

Polyomavirus large T antigen overcomes p53 dependent growth arrest.

J Doherty1, R Freund.   

Abstract

Polyomavirus transforms cells in culture and induces tumors in mice without apparent interaction with or inactivation of the p53 tumor suppressor protein. In this report we investigate the ability of polyomavirus T antigens to overcome the growth suppression function of p53. A temperature sensitive p53 gene was introduced into mouse embryo fibroblasts derived from a p53 null mouse, resulting in expression of a protein with a mutant conformation at 37 degrees C and a functionally wild-type conformation at 32 degrees C. We found that expression of p53 at 32 degrees C induced the cyclin-dependent kinase inhibitor p21/WAF1 and arrested cell growth in the G1/G0 phase of the cell cycle. Only the under-phosphorylated form of the retinoblastoma tumor suppressor protein (pRB) was detected in these growth arrested cells. We introduced both polyomavirus large T (LT) and middle T (MT) antigens into this cell line and showed that LT overcame p53-dependent growth arrest, while MT did not. In cells grown at 32 degrees C, LT expession led to cell proliferation and phosphorylation of pRB in the presence of p21. A mutant LT containing a defective pRB binding domain failed to overcome the growth arrest, indicating that interaction of LT with RB proteins is required to override p53 function. Although the polyomavirus T antigens do not interact with p53 directly, our results indicate that the virus, through LT, is able to interfere with the growth suppressive activity of p53.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9150359     DOI: 10.1038/sj.onc.1201025

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  11 in total

1.  Middle T antigen activation of signal transduction pathways does not overcome p53-mediated growth arrest.

Authors:  J Doherty; R Freund
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

2.  J domain-independent regulation of the Rb family by polyomavirus large T antigen.

Authors:  Q Sheng; T M Love; B Schaffhausen
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

Review 3.  Natural biology of polyomavirus middle T antigen.

Authors:  K A Gottlieb; L P Villarreal
Journal:  Microbiol Mol Biol Rev       Date:  2001-06       Impact factor: 11.056

4.  Induction and utilization of an ATM signaling pathway by polyomavirus.

Authors:  Jean Dahl; John You; Thomas L Benjamin
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

5.  pRB-dependent, J domain-independent function of simian virus 40 large T antigen in override of p53 growth suppression.

Authors:  O Gjoerup; H Chao; J A DeCaprio; T M Roberts
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

Review 6.  Oncogenic viruses and tumor glucose metabolism: like kids in a candy store.

Authors:  Evan Noch; Kamel Khalili
Journal:  Mol Cancer Ther       Date:  2012-01       Impact factor: 6.261

7.  Evidence of a role for phosphatidylinositol 3-kinase activation in the blocking of apoptosis by polyomavirus middle T antigen.

Authors:  J Dahl; A Jurczak; L A Cheng; D C Baker; T L Benjamin
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

8.  Induction and bypass of p53 during productive infection by polyomavirus.

Authors:  Dilip Dey; Jean Dahl; Sayeon Cho; Thomas L Benjamin
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

9.  Necdin, a p53-target gene, is an inhibitor of p53-mediated growth arrest.

Authors:  Julie Lafontaine; Francis Rodier; Véronique Ouellet; Anne-Marie Mes-Masson
Journal:  PLoS One       Date:  2012-02-15       Impact factor: 3.240

10.  Global Analysis of Mouse Polyomavirus Infection Reveals Dynamic Regulation of Viral and Host Gene Expression and Promiscuous Viral RNA Editing.

Authors:  Seth B Garren; Yuvabharath Kondaveeti; Michael O Duff; Gordon G Carmichael
Journal:  PLoS Pathog       Date:  2015-09-25       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.